Who are Passiflora ; Crataegus and Salix's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Cimicifuga + Hiperico, Sinupret extract coated tablets, BNO 1016.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/passiflora-crataegus-and-salix.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Passiflora ; Crataegus and Salix — Competitive Intelligence Brief

Passiflora ; Crataegus and Salix (Passiflora ; Crataegus and Salix) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Herbal combination / Phytotherapeutic agent. Area: Cardiovascular / Anxiolytic.

phase 3 Herbal combination / Phytotherapeutic agent Cardiovascular / Anxiolytic Small molecule Live · refreshed every 30 min

Target snapshot

Passiflora ; Crataegus and Salix (Passiflora ; Crataegus and Salix) — Marjan Industria e Comercio ltda. This herbal combination product works by promoting cardiovascular relaxation and mild sedation through the synergistic effects of passionflower's anxiolytic properties, hawthorn's cardiotonic effects, and willow's anti-inflammatory action.

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
Passiflora ; Crataegus and Salix TARGET	Passiflora ; Crataegus and Salix	Marjan Industria e Comercio ltda	phase 3	Herbal combination / Phytotherapeutic agent
Cimicifuga + Hiperico	Cimicifuga + Hiperico	Phytopharm Consulting Brazil	phase 3	Herbal combination / phytotherapeutic agent
Sinupret extract coated tablets	Sinupret extract coated tablets	Bionorica SE	phase 3	Herbal combination / phytotherapeutic agent
BNO 1016	BNO 1016	Bionorica SE	phase 3	Herbal combination / Phytotherapeutic agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Herbal combination / Phytotherapeutic agent class)

Bionorica SE · 1 drug in this class
Marjan Industria e Comercio ltda · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Passiflora ; Crataegus and Salix — Competitive Intelligence Brief. https://druglandscape.com/ci/passiflora-crataegus-and-salix. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab